EyeGene,Inc Logo

EyeGene,Inc

Develops gene/cell therapies & mRNA vaccines for age-related and ocular diseases.

185490 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 의왕시 양지편2로 13 2층, 의왕시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

EyeGene, Inc. is a clinical-stage biotechnology company focused on the research and development of innovative biopharmaceuticals. The company is pioneering gene and cell therapies to create transformative treatments for various conditions, with a historical focus on age-related and ocular diseases. Leveraging advanced technologies such as mRNA platforms and immunology, EyeGene develops a pipeline of novel therapeutics and vaccines. The company aims to become a global biopharmaceutical leader by advancing treatment and prevention through data-driven research to address unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-17 00:00
Registration Form
증권신고서(지분증권) (2025.11)
Korean 1.8 MB
2025-09-16 00:00
Share Issue/Capital Change
주요사항보고서(유상증자결정)
Korean 32.6 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.1 MB
2025-06-30 00:00
Regulatory News Service
투자판단관련주요경영사항(임상시험계획승인신청등결정) (4가 수막구균 접합백신 ‘EGMCV4의 국내 임상 제2/3상 임상시…
Korean 17.9 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.1 MB
2025-05-12 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 18.1 KB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 21.4 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 26.5 KB
2025-03-18 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.7 MB
2025-03-11 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 158.3 KB
2025-03-10 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 159.1 KB
2025-03-04 00:00
Regulatory News Service
투자판단관련주요경영사항(임상시험계획승인신청) (EGMCV4수막구균(혈청형 A, C, W135 및 Y군) 접합백신의 면역…
Korean 12.1 KB
2025-02-28 00:00
Legal Proceedings Report
투자판단관련주요경영사항(임상시험결과) (아이진 mRNA 기반 코로나19 예방백신 (EGCOVID) ‘이지코비드(EGC…
Korean 14.5 KB
2025-02-28 00:00
Regulatory News Service
투자판단관련주요경영사항(임상시험결과) (mRNA 기반 코로나19 예방 다가백신 이지코브투(EGCOVII) 호주 임상 제…
Korean 14.9 KB
2025-02-26 00:00
Legal Proceedings Report
투자판단관련주요경영사항(임상시험계획자진취하등) (4가 수막구균 접합백신 ‘EGMCV4의 국내 임상 3상 임상시험계획(I…
Korean 11.1 KB

Automate Your Workflow. Get a real-time feed of all EyeGene,Inc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for EyeGene,Inc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.